InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by DELUCCIA ROBERT J, Director. Director active across 1 companies, notably Acurx Pharmaceuticals, Inc.. Aggregated, 2 reports have been recorded. Total volume traded: €43k. The latest transaction was disclosed on 19 November 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€21,7025,034 shares@ €4.3111100.0% of flow
Common Stock
SEC:0001104659-21-142473·
Ideal exit: 16 Aug 2022 (T+270)
€21,7025,034 shares@ €4.31110.37% mcap50.0% of flow
Common Stock
SEC:0001104659-21-142473:0·
Ideal exit: 16 Aug 2022 (T+270)
2 of 2 declarations
About DELUCCIA ROBERT J
Robert J. DeLuccia is a Director at Acurx Pharmaceuticals, Inc. He contributes to the governance of the company by bringing his expertise in strategy and business development. Robert is involved in key decisions that influence the future of Acurx Pharmaceuticals.
